Clinical Report: Visualization of Knowledge Graphs in Pediatric Cardiomyopathy
Overview
This study systematically reviews global research on pediatric cardiomyopathy genetics from 2000 to 2024, revealing key themes and trends. It highlights the integration of genetic research into digital healthcare, emphasizing precision medicine and multi-omics approaches.
Background
Pediatric cardiomyopathy is a significant cause of heart failure and sudden cardiac death in children, necessitating improved genetic understanding for better management. The evolution of genetic testing technologies has transformed the diagnosis and treatment landscape, making it crucial for pediatric healthcare. Addressing this public health challenge requires a comprehensive understanding of the genetic underpinnings and their clinical implications.
Research on pediatric cardiomyopathy genetics has grown from 2000 to 2024, with 1,438 articles published.
The United States, China, and the United Kingdom are the leading contributors to this research.
Five core themes were identified, including disease classification and therapeutic mechanisms.
Research evolution has progressed through three phases: single-gene screening, multi-omics integration, and precision medicine.
Integration of multi-omics data and AI is enhancing personalized risk assessment and monitoring.
Clinical Implications
Healthcare professionals should prioritize genetic testing and counseling in pediatric cardiomyopathy management. The findings underscore the importance of integrating advanced genetic insights into clinical practice to improve patient outcomes and guide treatment strategies.
Conclusion
The study illustrates the rapid advancement of genetic research in pediatric cardiomyopathy, emphasizing the shift towards precision medicine and the integration of digital healthcare solutions. Continued exploration in this field is essential for enhancing pediatric cardiovascular health management.
